SPDR S&P Pharmaceuticals ETF $XPH Stock: Compass Wealth Management LLC Trims Position

Compass Wealth Management LLC decreased its position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 57.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 11,255 shares of the company’s stock after selling 15,397 shares during the period. Compass Wealth Management LLC owned about 0.16% of SPDR S&P Pharmaceuticals ETF worth $732,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE raised its stake in SPDR S&P Pharmaceuticals ETF by 128.0% during the 1st quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock valued at $43,918,000 after purchasing an additional 455,802 shares during the period. Parkway Wealth Management Group LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter valued at $24,754,000. Envestnet Portfolio Solutions Inc. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 5.3% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 180,521 shares of the company’s stock worth $11,963,000 after buying an additional 9,042 shares during the period. First Citizens Bank & Trust Co. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth $11,083,000. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the second quarter worth $3,350,000.

SPDR S&P Pharmaceuticals ETF Trading Up 0.5%

Shares of XPH stock opened at $64.28 on Friday. The company has a market capitalization of $453.17 million, a price-to-earnings ratio of 14.28 and a beta of 0.61. SPDR S&P Pharmaceuticals ETF has a 1-year low of $47.60 and a 1-year high of $74.35. The stock’s fifty day simple moving average is $67.55 and its 200-day simple moving average is $64.06.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.